Superdisintegrants Market Overview
Market Research Future (MRFR) speculates that the global superdisintegrants systems market is slated to garner USD 576.2 million, grabbing a CAGR of 8.0% during the forecast period (2022 to 2030). Increased production of generic drugs is predicted to is estimated to favor the market growth in the coming years. Disintegrants are referred to as substances which are generally included in drug formula in order to allow proper disintegration of the tablet or capsule into dissolvable particles. Superdisintegrants are added to drug formulation to facilitate the dissolution of the capsule content into reduced particles. Crospovidone, sodium starch glycolate, and croscarmellose sodium are some of the widely used products.
Superdisintegrants are extensively used in the production of drugs aimed at pediatric and geriatric patients as they provide good efficacy and disintegration at low dosage. With the rising incidences of several chronic diseases coupled with rapidly growing healthcare infrastructure, market is considered to propel. Governments from several economies are focusing on prevention rather than treatment, which has triggered the consumption of pharmaceuticals, thereby fostering the market growth. Moreover, advanced R&D activities is contributing to the growth of the Superdisintegrants Market. For instance, substances like gellan gum, soy polysaccharide, isapghula husk mucilage, karaya gum, and locust bean gum are some of the natural substances which can be used as superdisintegrants in solid dosage form.
The pharmaceutical sector is observed to grow at a breakneck and is becoming an important part of the healthcare sector owing to the increasing population of both pediatric as well as geriatric patients. Superdisintegrants help to treat patients of this demographic as these tablets can be swallowed easily. With the growth of the demographic, the market for Superdisintegrants is estimated to flourish. Generic drugs are also high in demand as patents are running out on popular drug brands, thereby opening up the pharmaceutical sector for rising entry of competition and increased manufacturing of generic drugs. This has further propelled the market demand for superdisintegrants across the globe.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6663
Superdisintegrants Market Segmentation
- The global superdisintegrants systems market has been segmented on the basis of formulation, type, and therapeutic area.
- By mode of type, the global superdisintegrants systems market has been segmented into natural disintegrants, synthetic superdisintegrants, and others. Among these, the synthetic Superdisintegrants occupies a major share as they are widely used in the formulation of drugs. On the other hand, natural Superdisintegrants are expanding at a rapid pace owing to the increased demand for natural ingredients.
- By mode of formulation, the global superdisintegrants systems market has been segmented into tablets and capsules. Among these, the tablets command a major share as they are easy to consume.
- By mode of therapeutic area, the global superdisintegrants systems market has been segmented into neurological diseases, gastrointestinal diseases, infectious diseases, oncology, hematological diseases, inflammatory diseases, and cardiovascular diseases. Among these, the gastrointestinal diseases occupy a major share owing to the demand for fast acting medicine for such kinds of diseases
Superdisintegrants Market Regional Analysis
Geographically, the superdisintegrants systems market span across regions namely, Europe, America, Asia Pacific, and the Middle East & Africa.
Among all the regions, the American region is considered go capture the largest market share, led by the U.S. The growth is credited to the presence of a well-developed healthcare infrastructure and prominent market players. Moreover, due to the rising prevalence of chronic diseases, the demand for drugs where superdisintegrants are required have increased, thereby influencing the market.
The Asia Pacific region is predicted to expand at the highest pace owing to the high concentration of rapidly emerging markets in this region. Country-level markets like India, China, and Japan have a high demand for drugs due to increased prevalence of chronic diseases. Moreover, with the presence of contract manufacturing organizations for pharmaceuticals and rapidly growing healthcare sector, the market for superdisintegrants systems is considered to foster.
Superdisintegrants Market Players
- Asahi Kasei Corporation
- DFE Pharma
- JRS Pharma
- Corel Pharma Chem
- Ashland Global Holdings Inc.
- BASF SE
- Roquette Freres
- DowDuPont Inc.
- Merck KGaA
- Avantor Performance Materials
- LLC
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/superdisintegrants-market-6663
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
